Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1814 results about "Hormone" patented technology

A hormone (from the Greek participle ὁρμῶν, "setting in motion") is any member of a class of signaling molecules, produced by glands in multicellular organisms, that are transported by the circulatory system to target distant organs to regulate physiology and behavior.

Compositions and methods for modulating circulating factors

In various embodiments, the disclosure provides compositions, such as polypeptides, polynucleotides, gene editing systems, small molecules, vectors, or host cells, comprising and / or modulating the expression or activity of an immunomodulatory-related protein. In various embodiments, the disclosure also provides for the treatment of aging, senescence, fibrosis, metabolic diseases, cardiovascular diseases, endocrine-related disorders, genetic diseases, cancer, infections, immune diseases, and the like using agents comprising and / or modulating the expression or activity of an immunomodulatory-related protein. Methods of replacing an adaptation of therapy or combinations thereof with hormones, growth factors and / or proteins, as well as methods of identifying the agents.
Owner:FLAGSHIP ENTREPRENEURSHIP & INNOVATION NO 7 CO LTD

Health degree evaluation system and method for endocrine nursing

The invention discloses a health degree assessment system and method for endocrine nursing, and relates to the technical field of health assessment, and the system comprises a state vector construction module which is used for collecting basic data of a patient, constructing an individual state vector S, collecting physiological data of the patient in real time, and extracting deep features by using a CNN model; and the anomaly detection module is used for performing dimensionality reduction on the deep features by using PCA, then inputting a mutation point detection algorithm to detect periodic mutation points to obtain a mutation point set, identifying peak activation response by using SNN to obtain a peak anomaly set, and integrating the obtained mutation point set and the peak anomaly set into an anomaly feature vector A. According to the method, dynamic and accurate evaluation of the health state of the endocrine patient is achieved, accurate multi-symptom risk prediction can be achieved through real-time monitoring and automatic recognition of hormone fluctuation, behavior abnormity and health state changes, a personalized nursing intervention plan can be generated according to the individual health state, and therefore the nursing efficiency is improved.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE

Construction method and system for reproductive medicine database

The invention relates to the technical field of database construction, in particular to a construction method and system for a reproductive medicine database. The method comprises the following steps: acquiring a biological tissue sample of a patient; acquiring reproductive endocrine hormone data, embryo morphological parameter data, immune cell function data and genome variation data from the biological tissue sample of the patient; performing time sequence analysis processing on the hormone fluctuation mode according to the reproductive endocrine hormone data to obtain endocrine dynamic characteristic data; performing image recognition processing based on coherent superposition characteristics of light on the embryo morphological parameter data, and performing embryo development potential evaluation to obtain embryo development potential data; and performing hierarchical clustering processing on the individual heterogeneity of the patient according to the immune cell function data and the genome variation data to obtain immune-genetic typing data of the patient. By means of the quantum dot sensing technology and the multi-channel micro-fluidic chip, standardization of data acquisition is achieved, and the heterogeneity problem of a data source is solved.
Owner:HUNAN FURUI BIOPHARMA TECH CO LTD

Thienopyrimidine derivatives and production methods thereof

The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1′-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.
Owner:TAKEDA PHARMA CO LTD

Preparation method of lipidosome containing hair-growing active ingredients

The invention provides a preparation method of lipidosome containing hair-growing active ingredients, and belongs to the technical field of hair-growing products. According to the invention, active substances are utilized to regulate hormone level, improve scalp blood circulation, stimulate anti-hair loss factors and promote hair growth in multiple directions, and lipidosome formed by lecithin and oil-soluble active ingredients as raw materials is utilized to integrally entrap the active substances, so that the anti-hair loss effect is improved. The defect of weak transdermal ability caused by large water solubility difference among the active substances is overcome, the stability and bioavailability of the active substances can be improved, and the hair growth and development effects of the prepared lipidosome containing the hair growth active components are remarkably improved.
Owner:BOHUI MEICUI BIOENGINEERING TECH (GUANGDONG) CO LTD

Fresh commodity after-ripening regulation and control planning method oriented to maturity grading

The invention discloses a fresh commodity after-ripening regulation and control planning method oriented to maturity grading, and relates to the technical field of food science and biologication.The method comprises the steps that physiological parameters of fresh commodities are collected in real time based on a multi-modal sensor, and the physiological parameters comprise the epidermis pigment content, the ethylene release rate, the fruit hardness and the respiration intensity; the collected physiological parameters are input into a multi-objective optimization model based on deep learning, the model fuses a metabolic kinetic equation and an LSTM time sequence prediction algorithm, and a regulation and control parameter combination adaptive to the current mature stage is output; according to the regulation and control parameter combination, the temperature, the relative humidity and the O2 / CO2 concentration gradient of the controlled atmosphere storage equipment are synchronously regulated through a distributed control system, and a plant hormone antagonist is injected through an ultrasonic atomization device; and constructing a supply chain collaborative network based on a block chain technology, binding a grading result with logistics path planning, and adjusting a temperature control strategy and a shelf life countdown parameter of the cold chain transport vehicle in real time through an edge computing node.
Owner:杜娟

Application of medicago sativa MsPL19 protein and gene thereof in regulating and controlling plant height, fresh weight or biological yield of medicago sativa

The invention relates to the technical field of plant genetic engineering, in particular to an application of an alfalfa MsPL19 protein and a gene thereof in regulating and controlling the plant height, fresh weight or biological yield of alfalfa. The invention provides an MsPL19 protein, a gene and application thereof, which can obviously improve the plant height, the biological yield and the fresh weight of medicago sativa and further improve the quality of the medicago sativa. Meanwhile, it is found that the MsPL19 protein and gene can respond to low temperature, drought, salt, hormone and other pathways, the protein interacting with MsPL19 is obtained through immunoprecipitation-mass spectrometry analysis, corresponding molecular modules can be enriched, the molecular mechanism of alfalfa MsPL19 responding to the low-temperature environment is analyzed, new cold-resistant varieties can be bred for alpine regions, and the application prospect is broad. And a new breeding direction is provided for increasing the yield of alfalfa.
Owner:CHINA AGRI UNIV

Compositions of thienopyrimidine derivatives

ActiveUS20250051353A1Organic chemistryMethoxyaminePerylene derivatives
The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1′-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.
Owner:TAKEDA PHARMA CO LTD

Osmanthus fragrans hormone-treated miRNA reference gene as well as primer and application thereof

The invention discloses a hormone-treated osmanthus fragrans miRNA reference gene as well as a primer and application thereof. According to the present invention, the optimal miRNA internal reference gene under hormone treatment is obtained, the miRNA internal reference under ethephon treatment is novel33 and ofr-miR159b-3p, the miRNA internal reference under ABA treatment is novel3 and ofr-miR159b-3p, the miRNA internal reference under MeJA treatment is ofr-miR159b-3p, novel8, novel2 and novel3, the miRNA internal reference under co-treatment of the three hormones is ofr-miR159b-3p, novel8 and novel3, and the current situation that the osmanthus fragrans miRNA fluorescent quantitative internal reference does not exist under the treatment of different hormones is filled with the PCR primer; powerful support is provided for expression quantification of related miRNA under treatment of different hormones of osmanthus fragrans.
Owner:HUBEI UNIV OF SCI & TECH +1

Artificial breeding method of black head fish

The invention provides an artificial breeding method of black head fish, and belongs to the technical field of aquaculture. The spawning induction method comprises the following steps: injecting spawning induction hormone into a female parent for breeding parent fish twice for artificial spawning induction to obtain fertilized eggs; during the incubation period of the fertilized eggs, micro-flow at 18-21 DEG C is adopted for artificial incubation, and the flow speed is controlled by water at different incubation stages until incubation and seedling emergence are achieved, so that the fry of the black head fish with the odd amount is obtained. According to the method, the oxytocic hormone is injected in a two-needle injection mode, the injection dosage of each needle is strictly controlled, ova and seminal fluid which are well developed can be obtained, meanwhile, the hatching conditions of the fertilized ova are controlled, the oxytocic rate of the black head fish is 100%, the fertilization rate is 89% or above, the hatching rate is 86% or above, large-scale artificial breeding of the black head fish is achieved, and the method is suitable for large-scale artificial breeding of the black head fish. The method has important significance for protecting the cyprinus carpio which is an endangered resource.
Owner:WATER ENG ECOLOGICAL INST CHINESE ACAD OF SCI +1

Rapid test method for screening short stature in children

This application discloses a rapid detection method for screening of dwarfism in children, which belongs to the field of intelligent medical technology. It includes the following steps: Step 1, accurately sampling through capillary effect, and automatically diluting the sample to ensure accurate concentration; Step 2, introducing the collected sample into a multi-channel microfluidic detection chip to achieve parallel quantitative detection of endocrine hormones; Step 3, real-time acquisition and amplification of weak biomolecule recognition signals to effectively improve the signal-to-noise ratio; Step 4, multi-dimensional analysis of the test results to achieve quantitative evaluation of growth and development, body mass index and sexual development indicators and risk prediction of endocrine diseases; Step 5, automatically integrating the analysis results and generating a standardized test report; Step 6, establishing a quality control mechanism throughout the entire detection process, including real-time monitoring of sample quality, tracking of detection process parameters, result consistency evaluation, and full traceability of detection data.
Owner:HANGZHOU LINPING DISTRICT MATERNAL & CHILD HEALTH HOSPITAL

Method for improving grease titer by regulating schizochytrium limacinum fermentation process through plant hormones and application

The invention belongs to the technical field of biology, and discloses a method and application for regulating and controlling the fermentation process of schizochytrium limacinum through plant hormones to improve the oil titer, and the method is characterized in that in the fermentation process of schizochytrium limacinum, one or more plant hormones are added into a culture medium to promote accumulation of oil. Plant hormones are added into a fermentation culture medium of schizochytrium limacinum, the plant hormones comprise gibberellin (GB), 6-benayl aminopurine (6-BAP), forchlorfenuron (CPPU) and brassinolide (BR), and the plant hormones promote grease accumulation by adjusting activity of enzymes related to fatty acid synthesis, so that the plant hormones can adjust metabolic pathways of the schizochytrium limacinum and promote grease accumulation. The synthesis efficiency and the yield of the grease are obviously improved.
Owner:NANJING NORMAL UNIVERSITY

Application of isorhamnetin-3-O-neohesperidin in preparation of medicine for preventing and / or treating benign prostatic hyperplasia

The invention discloses an application of isorhamnetin-3-O-neohesperidin in preparation of a medicine for preventing and / or treating benign prostatic hyperplasia. In-vitro experiments show that the isorhamnetin-3-O-neohesperidin can inhibit proliferation of prostatic hyperplasia cells, promote apoptosis of the prostatic hyperplasia cells and regulate inflammatory response of the prostatic hyperplasia cells, and rat experiments show that the isorhamnetin-3-O-neohesperidin can improve the hormone endocrine disorder condition of an animal model body, and can inhibit the prostatic hyperplasia cells and promote the prostatic hyperplasia cell apoptosis and regulate the inflammatory response of the prostatic hyperplasia cells. The anti-inflammatory ability of an animal model is enhanced, and the traditional Chinese medicine composition has a relatively good treatment effect on prostatic hyperplasia caused by testosterone propionate. The medicine for preventing and / or treating benign prostatic hyperplasia, provided by the invention, contains a pharmacodynamic dose of isorhamnetin-3-O-neohesperidin and a pharmaceutically acceptable carrier or auxiliary material, can be prepared into a medicine dosage form which is convenient for clinical use and can play an optimal curative effect, and has a relatively high clinical application value.
Owner:CHINA PHARM UNIV

Thyroid hormone receptor beta agonist compounds

PendingUS20250236615A1Organic chemistryMetabolism disorderThyroid hormone receptor betaAgonist
Provided herein are compounds, preferably thyroid hormone receptor beta (THR beta) agonist compounds, compositions thereof, and methods of their preparation, and methods of agonizing THR beta and methods for treating disorders mediated by THR beta.
Owner:TERNS INC

Temperature-corrected analyte detection method

The invention provides a temperature-corrected analyte detection method, and relates to the following steps: after a series of analyte calibrators with different concentrations are added into an immunoassay test strip, measuring a signal value generated after the analyte calibrator with each concentration is captured on a detection pad of the immunoassay test strip at each segmented temperature point by using an optical analyzer; drawing a corresponding equation by taking the T / C value at each segmented temperature point as an X axis and the concentration of the analyte calibrator as a Y axis; and then, according to the selected n segmented temperature points, carrying out temperature segmentation, and in different temperature segments, carrying out calculation by adopting different formulas. The analyte detection method subjected to temperature correction can be used for more accurately detecting myocardial markers, upper respiratory virus infection, metabolic hormones, digestive tract series markers, allergens and the like on the basis of a time-resolved fluorescence immunoassay test.
Owner:ACON BIOTECH (HANGZHOU LINAN) CO LTD

Methods and Apparatus to Stimulate the Heart

A method and apparatus for treatment of hypertension and heart failure by increasing secretion of endogenous atrial hormones by pacing of the heart. Pacing is done during the ventricular refractory period resulting in premature atrial contraction that does not result in ventricular contraction. Pacing results in the atrial wall stress, peripheral vasodilation, ANP secretion. Concomitant reduction of the heart rate is monitored and controlled as needed with backup pacing.
Owner:BACKBEAT MEDICAL INC

Methods and apparatus to stimulate the heart

A method and apparatus for treatment of hypertension and heart failure by increasing secretion of endogenous atrial hormones by pacing of the heart. Pacing is done during the ventricular refractory period resulting in premature atrial contraction that does not result in ventricular contraction. Pacing results in the atrial wall stress, peripheral vasodilation, ANP secretion. Concomitant reduction of the heart rate is monitored and controlled as needed with backup pacing.
Owner:BACKBEAT MEDICAL INC

Skin care composition for improving female climacteric aging and application thereof

The invention relates to a skin care composition for improving female climacteric aging and application thereof, and the skin care composition for improving female climacteric aging comprises the following components: conotoxin peptide, bakuchiol, alfalfa extract and radix pseudostellariae extract, the weight ratio of the conotoxin peptide to the bakuchiol to the alfalfa extract to the radix pseudostellariae extract is (0.1-5): (0.1-3): (0.1-5): (0.1-3). By means of inhibiting neurotransmitters, regulating hormones and the like, skin health is enhanced, the problem of skin aging of menopause women is effectively solved, and the skin is tight and smooth.
Owner:N O D TOPIA (GUANGZHOU) BIOTECHNOLOGY CO LTD

Nitrogen-containing condensed ring compound

The present invention addresses the problem of providing a novel compound that has a thyroid-stimulating hormone receptor antagonistic activity and is useful for the treatment of thyroid-related diseases. The present invention relates to a nitrogen-containing condensed ring compound represented by formula (A-I) or a pharmacologically acceptable salt thereof. The present invention relates to a nitrogen-containing condensed ring compound represented by formula (A-I) or a pharmacologically acceptable salt thereof. The compound or the pharmacologically acceptable salt thereof according to the present invention has an antagonistic activity against thyroid-stimulating hormone receptors and is therefore useful as a therapeutic agent for thyroid-related diseases (e.g., hyperthyroidism, Graves' disease, thyroid eye disease, and thyroid cancer) and others.
Owner:KISSEI PHARMACEUTICAL CO LTD

Tricyclic compound, and preparation method therefor and use thereof

A tricyclic compound, and a preparation method therefor and the use thereof. The present invention relates to a compound as shown in general formula (I), a preparation method therefor, a pharmaceutical composition containing the compound, and the use thereof in the preparation of a drug for treating or preventing autoimmune diseases, inflammatory diseases, cancers, viral diseases, neurodegenerative diseases, genetic disorders, hormone-related diseases, metabolic disorders, organ-transplantation-related diseases, immunodeficiency disorders, destructive bone diseases, proliferative disorders, infectious diseases, cell-death-related conditions and cardiovascular diseases. Each substituent in general formula (I) is as defined in the description.
Owner:SHANGHAI HUILUN BIOLOGICAL TECH CO LTD

Fertilized roe hatching equipment and use method thereof

The invention discloses fertilized roe hatching equipment and a using method thereof, and relates to the technical field of roe hatching, the fertilized roe hatching equipment comprises a hatching barrel, four corrugated plates are arranged in the hatching barrel, and a lifting mechanism for enabling the four corrugated plates to move is arranged on the hatching barrel. When the roe hatching device is used, roes are collected through the corrugated plate, the collected corrugated plate is placed in the hatching barrel, water in the hatching barrel is heated and inflated through the heating rod, the temperature sensor and the micro air pump every day, meanwhile, one third of the water in the hatching barrel is replaced regularly every day, and the water quality is guaranteed; when the yolk sacs of the larva fishes basically disappear and the swimming bladders are formed, the individuals can swim flatly and can be put into the pond for continuous cultivation, so that the inseminated eggs can be obtained without injecting oxytocic hormone for artificial spawning induction, the labor amount of workers is reduced, meanwhile, when the eggs are hatched and collected, the stimulation to the parent fishes is small, and the loss of the parent fishes is reduced.
Owner:LIAONING FRESHWATER FISHERIES RES INST

Compounds and their uses as thyroid hormone receptor agonists

A compound of formula (I) or (Ia), or a tautomer or a pharmaceutically acceptable salt thereof is provided. Compounds of formula (II) to (V), or a tautomer or a pharmaceutically acceptable salt thereof are also provided. These compounds and the pharmaceutical compositions containing them are useful for the treatment of diseases such as obesity, hyperlipidemia, hypercholesterolemia and diabetes and other related disorders and diseases, and may be useful for other diseases such as NASH, atherosclerosis, cardiovascular diseases, hypothyroidism, thyroid cancer and other disorders and diseases related thereto. (I), (Ia)
Owner:NANJING RUIJIE PHARMATECH CO LTD

Blood pressure dynamic monitoring and risk assessment system based on artificial intelligence

The invention relates to the technical field of blood pressure dynamic monitoring systems, and provides an artificial intelligence-based blood pressure dynamic monitoring and risk assessment system, which comprises a patient terminal, a doctor terminal, a data center terminal, a local anomaly detection terminal and a strategy generation terminal, the patient terminal is used for collecting blood pressure, body position change and endocrine hormone fluctuation data of a patient in real time; the data center terminal is used for fusing, storing and processing the data uploaded by the patient terminal and performing overall risk assessment; the local anomaly detection terminal is used for collecting local blood flow rate and pulse wave conduction velocity data and carrying out local anomaly detection index analysis; the strategy generation terminal is used for generating strategy information according to the overall risk assessment result and the local anomaly detection index; and the doctor terminal is used for receiving and displaying the overall risk assessment result and the local anomaly detection index, and receiving and executing the strategy information. According to the invention, the comprehensiveness and timeliness of hypertension risk prediction and intervention are improved.
Owner:THE THIRD XIANGYA HOSPITAL OF CENT SOUTH UNIV

Construction method and application of toxoplasma gondii gene knockout vaccine strain

The invention belongs to the technical field of gene engineering, and particularly discloses a construction method and application of a toxoplasma gondii gene knockout vaccine strain, a TGGT1202920 gene of toxoplasma gondii is directly knocked out through a gene editing technology to obtain a delta TGGT1202920 strain, and the strain has the characteristics that the strain can be normally cultured in vitro and is almost non-toxic in vivo; after animals are immunized with delta TGGT1202920 strains, good immune protection can be generated, infection of wild type toxoplasma gondii can be resisted, and the strain can be used for preparing toxoplasmosis resistant vaccines to prevent toxoplasma gondii infection.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Preparation method of spleen-tonifying and stomach-nourishing nutritional preparation

The invention provides a spleen and stomach conditioning factor lactobacillus reuteri obtained by fermenting poria cocos powder. The strain has good acid resistance, cholate resistance and antibacterial ability. The invention further provides a probiotic preparation which has an obvious effect on improving the spleen and the stomach. In addition, the invention also provides a composite preparation composition containing Lactobacillus reuteri, and the composition effectively promotes normal peristalsis and digestion and absorption functions of gastrointestinal tracts by regulating the secretion level of gastrointestinal hormones, enhances the immunity of the organism, protects intestinal mucosa barriers, comprehensively improves the symptoms of weakness of the spleen and the stomach, and improves the overall health level.
Owner:HUNAN NUTRITION TREE BIOTECHNOLOGY CO LTD

Pharmaceutical composition for promoting aTreg cell differentiation and application thereof

The invention discloses a pharmaceutical composition for promoting aTreg cell differentiation and application thereof, and relates to the field of biological medicine, and the pharmaceutical composition comprises zinc salt, a basic cell culture medium, fetal calf serum, antibiotic, L-glutamine and a pH buffer agent. According to the application, the basic cell culture medium is used for providing basic nutrition required by cell growth for lymphocytes, the fetal calf serum is used for providing growth factors, hormones, adhesion proteins and nutrient substances required by cell growth for the lymphocytes, and the antibiotics are used for preventing bacterial infection; l-glutamine provides key amino acid for cell energy metabolism and participates in synthesis of protein and nucleic acid, zinc salt provides zinc ions, and under the comprehensive action, the proportion of Treg cells and aTreg cells differentiated from lymphocytes in peripheral blood mononuclear cells is increased.
Owner:RENMIN HOSPITAL OF WUHAN UNIVERSITY (HUBEI GENERAL HOSPITAL)

Plant lactobacillus MG360 capable of improving constipation, compound probiotic fermentation preparation and application of compound probiotic fermentation preparation

The invention provides a lactobacillus plantarum MG360 with the efficacy of improving constipation, the preservation number of the lactobacillus plantarum MG360 is CGMCC NO 32953, and the lactobacillus plantarum MG360 is preserved in China General Microbiological Culture Collection Center on February 14, 2025. Meanwhile, the invention further provides a compound probiotic composition of the plant lactobacillus MG360 and the lactobacillus rhamnosus Eupro, the compound probiotic composition can be used for fermenting the coix seed enzymatic hydrolysate, and a fermentation product of the compound probiotic composition is rich in ferulic acid, vanillic acid, short-chain fatty acid, glutamic acid and the like. The fermentation product can obviously shorten the first black excrement discharge time of constipation mice, obviously improve the small intestine propulsion rate and the excrement water content, obviously improve the level of motility hormone (MTL, Gas, AchE, SP and 5-HT) in serum of the constipation mice and obviously reduce the level of inhibitory hormone (SS and VIP), and it is indicated that the fermentation product can relieve constipation by adjusting the gastrointestinal hormone peptide level. The preparation method of the probiotic preparation containing the plant lactobacillus MG360 and the compound probiotic fermentation preparation of the compound probiotic composition is simple, large-scale production can be achieved, and good application prospects are achieved.
Owner:HUNAN NUTRITION TREE BIOTECHNOLOGY CO LTD

Application of rice OsPBL8 gene in enhancing resistance of rice to magnaporthe oryzae

The invention relates to the technical field of biology, in particular to application of a rice OsPBL8 gene in enhancing resistance of rice to magnaporthe oryzae. The rice OsPBL8 gene is a rice endogenous gene participating in the processes of plant growth and development, abiotic stress response, hormone signal channel regulation and control and the like. The invention provides application of the OsPBL8 gene in the field of disease resistance, the OsPBL8 gene is overexpressed through gene editing, and the expression quantity of receptor-like cytoplasm kinase OsPBL8 in plants is increased, so that a plurality of signal channels are regulated and controlled, and the germ resistance of the plants is synergistically improved. By adjusting key hub nodes of plant targeted immune signal transduction, more lasting broad-spectrum disease resistance can be provided, good universality is achieved, disease resistance and growth can be balanced, good practicability is achieved, and improvement of disease resistance of various rice varieties is facilitated.
Owner:SUZHOU UNIV